Manappuram Finance. Institutional Equities. 2QFY19 Result Update BUY

Size: px
Start display at page:

Download "Manappuram Finance. Institutional Equities. 2QFY19 Result Update BUY"

Transcription

1 2QFY19 Result Update Manappuram Finance 9 November 2018 Reuters: MNFL.BO; Bloomberg: MGFL IN Positive All-round Results Should Set The Tone Manappuram Finance (MFL) reported its 2QFY19 results with the key pointers being: (1) Gold loan AUM growth at 1% QoQ was softer than past 3-quarter average of 5% but was impacted by physical gold price deflation (2) MFI subsidiary Asirvad augmented consolidated RoE for the second quarter running by delivering an RoE of 28% for 2QFY19 (3) Non-gold non-mfi businesses continued to see good traction underlining embedded operating leverage. Share of non-gold loans in total AUM rose 170 bps QoQ to 26.7% (4) Security costs, an opex worry some quarters ago, has been reined in via technology initiatives. (See comprehensive conference call takeaways below; see initiating coverage report here). Per se, on the results front, MFL posted NII growth of 19% YoY and 9% QoQ at Rs6,738mn, PPOP growth of 28% YoY and 13% QoQ at Rs3,662mn and PAT growth of 39% YoY and 12% QoQ at Rs2,222mn. We have revised our estimates for FY19/FY20/FY21 and retained Buy rating on MFL, revising our target price to Rs112 (from Rs103 earlier), valuing the stock at 1.6x 1HFY21E P/BV. Gold loan AUM growth at 1% QoQ was softer than past 3-quarter average of 5% but was impacted by physical gold price deflation: Gold loan AUM growth lagged gold holdings growth of 2.1% QoQ due to gold price deflation during the quarter. We do not think Gold price deflation is a sustainable theme since (1) we believe the froth had exited the global gold prices once the long-term global gold bear market ended in 2016 and such bear markets for gold are once-in-a-generation themes (2) Indian gold prices are protected by an INR depreciation overlay, which is a long-term structural expectation. Indeed, Indian gold prices have bounced back and have recently traded at 6-year highs. Importantly, structural revival in gold lending has been underway since 2QFY18-end with gold AUM growth of 17% YoY in 2QFY19, which is a fairly attractive growth rate for loans against gold, given it is a business of high sustainable margin and low credit costs and, thus of high steady state RoA. Management had earlier stated LGD for the business is just 63 bps. The business has great recourse to passing on rising cost of funds to customers and this was witnessed in the 80 bps QoQ rise in net yield for MFL due to the discontinuance interest waivers on online gold loans. Liquidity issues arising out ALM mismatch are a non-issue for gold lending and more so MFL because of the vast majority of its gold loans tenure being capped at 3 months. Average effective tenure for MFL gold loans is ~2 months. MFI subsidiary Asirvad augmented consolidated RoE for the second quarter running by delivering an RoE of 28% for 2QFY19: Asirvad Microfinance saw its portfolio grow 12% QoQ and its geographical diversification journey continued apace. Non-south regions contributed 54% to AUM compared with 42% 12 months ago. Tamil Nadu alone contributed ~80% to AUM at the time of being acquired by MFL but this has declined to below 30% currently. Asirvad has no exposure to commercial paper and has not faced any funding issues. In any case, the nature of Asirvad s lending is also short-term in nature leading to positive ALM gap. Non-gold non-mfi businesses continued to see good traction underlining embedded operating leverage. Share of non-gold loans in total AUM rose 170 bps QoQ to 26.7%: Vehicle finance, in particular, continued its stellar performance, growing 95% YoY. It remains a business of outsized embedded operating leverage as it is carried out from existing gold loan branches, which are 3330 in number. The housing finance business, which was in a state of flux a few quarters ago, seems to have stabilized with pace of NPA accretion slowing down. GNPA ratio for the business inched up ~10 bps QoQ to 4.7%. Management stated that they are hopeful of a positive revert from RBI on the ISFC acquisition front in a month or so since they have made a representation to the regulator in this regard. Valuation and outlook: We have retained our NII estimates, revised our PPOP estimates by -1.5%/0.8%/0.3% and PAT estimates by -2.4%/1.5%/0.2% for FY19/FY20/FY21, respectively. We have retained Buy rating on MFL, valuing the stock at 1.6x 1HFY21E P/BV and revising our target price to Rs112 (from Rs103 earlier). BUY Sector: NBFC CMP: Rs83 Target Price: Rs112 Upside: 36% Shivaji Thapliyal Research Analyst shivaji.thapliyal@nirmalbang.com Key Data Current Shares O/S (mn) Mkt Cap (Rsbn/US$bn) 95.1/ Wk H / L (Rs) 130/82 Daily Vol. (3M NSE Avg.) 3,826,635 Price Performance (%) 1 M 6 M 1 Yr Manappuram Finance Nifty Index Source: Bloomberg Y/E March (Rsmn) 2QFY19 2QFY18 1QFY19 YoY (%) QoQ (%) Interest income 9,911 8,109 9, Interest expenses 3,173 2,448 2, Net interest income 6,738 5,661 6, Calculated NIM (%) (53bps) 76 bps Fee & other income Operating income 7,102 5,954 6, Staff costs 1,773 1,557 1, Other operating expenses 1,668 1,533 1, Total operating expenses 3,440 3,090 3, Cost to-income (%) (345bps) (180bps) Cost-to-AUM (%) (100bps) (10bps) Operating profit 3,662 2,864 3, Provisions (64.2) 4.9 Credit costs (%) (95bps) - PBT 3,499 2,411 3, Tax/ Minority Interest 1, , Effective tax rate bps 58 bps Adjusted PAT 2,222 1,598 1, Other comprehensive income (8) (16) 6 NA NA Total Comprehensive Income 2,214 1,582 1, EPS (Rs) AUM (Rsmn) 171, , , Source: Company, Nirmal Bang Research

2 Comprehensive Conference Call Takeaways Asset Quality The management stated that the impact of Kerala floods was only seen in delay in collections. They didn t witness any credit loss due to the same. The management stated that the auctions amounted to Rs1,040mn during the quarter. Manappuram Finance has been making provisions in excess of IndAS norms. The management stated that they continue to provide on gold loans as per RBI norms, which exceed IndAS norms. The management stated that they have not taken any RBI dispensation for provisioning arising from Kerala floods. Exposure to Kerala stands at ~6% of the consolidated AUM. In Kerala, MFI book stands at Rs2,000mn, vehicle finance book at Rs300mn and HFC book at Rs200mn. The management stated that they are not expecting any credit loss from any business due to Kerala floods. The management stated that only the small and medium sized MFIs of AUM less than Rs10bn have seen problems. In the last 30 days microfinance lending rate has been hiked by 25bps in line with rise in borrowing cost. The management stated that the NBFC book stood at Rs5,600mn. 20% of this amount was to MFIs, in which regular collections are being made. Rest of the NBFC book comprises CV lenders and MSME lenders. The management stated that after systemic issues such as demonetization, awareness regarding the cost of spoiling one s credit history by default is rising. The management categorically stated that the MFI loans are not included in farm loan waivers. Loan and Business Growth The management stated that the overall growth was reasonable despite the monsoon season turning out to be somewhat below par. The management stated that the lower gold prices impacted QoQ gold loan AUM growth. They have provided a 10-12% gold loan growth guidance for FY19. The management is targeting the non-gold loan book to contribute 50% of the total loan book by the next 10 years. The management stated that a total of Rs3,370mn worth of disbursements were made during the quarter. The management stated that the breakeven level is Rs15mn AUM per branch. Margin, Liabilities and Liquidity Marginal cost of borrowing rate rose 11bps QoQ to 8.88%. The management explained that ~90% of consolidated AUM (gold loans + microfinance) is short-term in nature and therefore ALM problems do not exist for MFL. The management stated that the weighted average LTV on gold loans was 66%. The management stated that the schemes which provided aggressive discounts were discontinued and they will not be brought back. This was a timely action in an increasing borrowing cost environment. The management stated that more than 50% of the NCD borrowings came from institutions which are generally of medium to long term tenure and about 10% came from retail NCDs. 2 Manappuram Finance

3 The management stated that the average actual tenure of the gold loans stood at around 60 days. Overall, the NBFC has a high capital adequacy and good credit rating. All CPs have been renewed and so have all bank contracts. The average tenure of CPs is days. The management guided that the current liability mix will continue and stressed on the point that the lenders have an understanding of Manappuram Finance s positive ALM position. Operating Expenses Employee count stood at 25,104 as of this quarter end. On the technology front, the management stated that they develop their own technology as well as through outsourcing. On the gold loan book, they use their in-house technology. For the vehicle loan book, they outsource it. They also use some of the analytics platforms. The whole NBFC s IT infrastructure is handled by IBM. The total technology cost amounts to Rs400mn. The management stated that their branch network is new compared to their key competitors, which explains their lower AUM per branch. They are planning to add 100 branches a year going forward. The management stated that the security costs are coming down Rs50mn per quarter due to technology initiatives. It will stabilize at Rs750mn levels, which earlier was at ~Rs1,400mn. Subsidiaries and Cross-Sell On the investment made in ISFC, the management stated that initially RBI did not give approval, but they have made a representation to RBI. The management believes the outcome will be positive and one should hear from RBI in a month. Borrowing mix of Asirvad Microfinance is as follows: bank borrowings 30%, NBFC borrowing 16%, securitization 10% and the rest is NCDs. There is no exposure to commercial borrowing. In Asirvad Microfinance, to begin with, 80% of the total portfolio originated in Tamil Nadu. Now, the total portfolio has spread across 21 states and more states are in the pipeline to be added. Tamil Nadu exposure has reduced to less than 30% and the management is targeting an year-end figure of 25%. Each of the other states has a share of less than 10%. The management stated that they have an insurance broking subsidiary which has an income of over Rs100mn now. With more branches, customers and products, the management believes the firm will scale up on the cross-sell front. On Asirvad Finance, the management stated that they will build Rs4-5bn of micro enterprise portfolio in the next months. The management has indicated that they would like to list Asirvad Microfinance but have not picked any timeline as such. On their gold and MFI loan book, total customers stood at 4.5mn. The management stated that given their expanding customer base they will explore all opportunities of cross-selling. Some of the crossselling loan offerings are 2-wheelers, affordable housing. They are also planning to start micro enterprise lending. 3 Manappuram Finance

4 May-10 Nov-10 May-11 Nov-11 May-12 Nov-12 May-13 Nov-13 May-14 Nov-14 May-15 Nov-15 May-16 Nov-16 May-17 Nov-17 May-18 Nov-18 Exhibit 1: Financial summary Y/E March (Rsmn) FY17 FY18 FY19E FY20E FY21E Net interest income 22,075 23,815 25,786 28,745 34,464 Pre-provision profit 12,749 14,063 14,940 16,745 21,780 PAT 7,584 6,684 8,664 9,809 12,803 EPS (Rs) BV (Rs) P/E (x) P/BV (x) Gross NPAs (%) Net NPAs (%) RoA (%) RoE (%) Source: Company, Nirmal Bang Research Exhibit 2: Actual performance versus our estimates (Rsmn) 2QFY19 2QFY18 1QFY19 YoY (%) QoQ (%) 2QFY19E Devi. (%) Net interest income 6,738 5,661 6, , Pre-provision profit 3,662 2,864 3, , PAT 2,222 1,598 1, , Source: Company, Nirmal Bang Research Exhibit 3: Change in our estimates Revised estimate Earlier estimate % Revision FY19E FY20E FY21E FY19E FY20E FY21E FY19E FY20E FY21E Net interest income (Rsmn) 25,786 28,745 34,464 25,786 28,745 34, NIM (%) Operating profit (Rsmn) 14,940 16,745 21,780 15,171 16,617 21,720 (1.5) Profit after tax (Rsmn) 8,664 9,809 12,803 8,876 9,665 12,782 (2.4) Source: Company, Nirmal Bang Research Exhibit 4: One-year forward P/BV (x) P/BVPS Mean +1 SD -1 SD +2 SD -2 SD Source: Company, Nirmal Bang Research 4 Manappuram Finance

5 Financials Exhibit 5: Income statement Y/E March (Rsmn) FY17 FY18 FY19E FY20E FY21E Interest income 33,762 34,092 38,949 44,263 53,436 Interest expenses 11,687 10,277 13,163 15,519 18,973 Net interest income 22,075 23,815 25,786 28,745 34,464 Non-interest income ,257 Net revenues 22,401 24,489 26,536 29,655 35,720 Operating expenses 9,652 10,426 11,596 12,911 13,940 -Employee expenses 5,026 6,167 6,698 7,523 8,014 -Other expenses 4,626 4,259 4,898 5,388 5,927 Operating profit 12,749 14,063 14,940 16,745 21,780 Provisions 1,093 3,893 1,610 1,654 2,084 PBT 11,656 10,170 13,330 15,091 19,696 Tax 4,072 3,486 4,665 5,282 6,894 PAT 7,584 6,684 8,664 9,809 12,803 Source: Company, Nirmal Bang Research Exhibit 7: Balance sheet Y/E March (Rsmn) FY17 FY18 FY19E FY20E FY21E Share capital 1,684 1,685 1,685 1,685 1,685 Reserves & surplus 31,934 36,677 43,268 50,964 61,594 Net worth 33,618 38,362 44,954 52,649 63,279 Borrowings 109, , , , ,063 Other liability & provisions 8,042 8,000 9,273 11,387 12,715 Total liabilities 151, , , , ,597 Fixed assets 1,869 2,746 3,158 3,631 4,176 Investments Loans 138, , , , ,288 Cash 5,227 6,986 7,496 8,650 10,613 Other assets 5,958 5,907 7,567 8,860 10,469 Total assets 151, , , , ,597 Source: Company, Nirmal Bang Research Exhibit 6: Key ratios Y/E March (Rsmn) FY17 FY18 FY19E FY20E FY21E Growth (%) Net interest income Operating profit Profit after tax (11.9) Business (%) Advances growth Spread (%) Yield on loans Cost of borrowings Spread NIM Operational efficiency (%) Cost-to- income Cost- to-assets Productivity (Rsmn) AUM per branch AUM per employee Employee per branch CRAR (%) Tier I Tier II Total Asset quality (%) Gross NPAs Net NPAs Specific provision coverage Credit costs (excluding std. assets) Credit costs (including std. assets) Return ratios (%) RoE RoA Per share (%) EPS BV ABV Valuation (x) P/E P/BV P/ABV Source: Company, Nirmal Bang Research 5 Manappuram Finance

6 Apr-17 May-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Rating track Date Rating Market price (Rs) Target price (Rs) 26 March 2018 Buy February 2018 Buy August 2018 Buy October 2018 Buy November 2018 Buy Rating track graph Not Covered Covered 6 Manappuram Finance

7 DISCLOSURES This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) for private circulation. NBEPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 2014 having Registration no. INH NBEPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: I, Shivaji Thapliyal, the research analyst is the author of this report, hereby certifies that the views expressed in this research report accurately reflects my personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 7 Manappuram Finance

8 Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBEPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBEPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBEPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBEPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBEPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBEPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBEPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBEPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBEPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBEPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBEPL. Our reports are also available on our website Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com , Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com /8101, Michael Pillai Dealing Desk michael.pillai@nirmalbang.com /8103, Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 301/302, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai Board No. : /1; Fax. : Manappuram Finance

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018 4QFY18 Result Update Institutional Equities South Indian Bank 15 May 2018 Reuters: SIBK.BO; Bloomberg: SIB IN Asset Quality Pain To Ease Hereafter South Indian Bank (SBL) reported 4QFY18 results with the

More information

Punjab National Bank

Punjab National Bank 4QFY18 Result Update Institutional Equities Punjab National Bank 16 May 2018 Reuters: PNB.BO; Bloomberg: PNB IN Prompt Corrective Action Looms Punjab National Bank (PNB) reported its 4QFY18 results with

More information

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018 3QFY18 Result Update Institutional Equities Manappuram Finance 9 February 2018 Reuters: MNFL.BO; Bloomberg: MGFL IN The Glitter Is Back In Gold Loans Manappuram Finance (MFL) reported its 3QFY18 results

More information

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY. 3QFY18 Result Update Institutional Equities Muthoot Finance 12 February 2018 Reuters: MUTT.BO; Bloomberg: MUTH IN Funding Cost Decline Combines With Operating Leverage Muthoot Finance (MFL) reported its

More information

Punjab National Bank

Punjab National Bank Company Update Punjab National Bank 19 September 2018 Reuters: PNB.BO; Bloomberg: PNB IN Concerns Remain; Assign Accumulate We take Punjab National Bank (PNB) out from Under Review and assign an Accumulate

More information

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018 4QFY18 Result Update Institutional Equities PNB Housing Finance 4 May 2018 Reuters: PNBH.NS; Bloomberg: PNBHOUSI IN Continued Display of Embedded Scalability PNB Housing Finance (PNBHF) reported 4QFY18

More information

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018 2QFY19 Result Update Institutional Equities Muthoot Finance 10 December 2018 Reuters: MUTT.BO; Bloomberg: MUTH IN Weak quarter not structural in any way Muthoot Finance (MFL) reported its 2QFY19 results

More information

2,09,057 1,85,859 2,17, (4.1) NIM

2,09,057 1,85,859 2,17, (4.1) NIM 2QFY19 Result Update Institutional Equities State Bank of India 6 November 2018 Reuters: SBI.BO; Bloomberg: SBIN IN Domestic Credit Growth Improves Materially State Bank of India (SBI) reported its 2QFY19

More information

Institutional Equities

Institutional Equities 4QFY18 Result Update Institutional Equities Atul Auto 30 May 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Mar Profitability Atul Auto s (AAL) 4QFY18 earnings missed our expectations on account

More information

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance 2QFY19 Result Update Gillette India 13 February 2019 Reuters: GILE.NS; Bloomberg: GILL IN Marketing Investments Mask Improved Top-line Performance Gillette India s (GILL) 2QFY19 operating and net earnings

More information

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature. 2QFY19 Result Update Institutional Equities PNB Housing Finance 6 November 2018 Reuters: PNBH.NS; Bloomberg: PNBHOUSI IN Relatively Soft Quarter Not Structural In Nature PNB Housing Finance (PNBHF) reported

More information

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN 4QFY18 Result Update Institutional Equities Karnataka Bank 17 May 2018 Reuters: KBNK.NS; Bloomberg: KBL IN Plucky Bank And Low Hanging Fruit Karnataka Bank (KBL) reported 4QFY18 results with the key strategic

More information

Indian Oil Corporation

Indian Oil Corporation 3QFY18 Result Update Institutional Equities Indian Oil Corporation 1 February 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Earnings Outperformance On Account Of Inventory Gains Indian Oil Corporation (IOCL)

More information

Gillette India. Institutional Equities. 1QFY18 Result Update

Gillette India. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update Institutional Equities Gillette India 14 November 2017 Reuters: GILE.NS; Bloomberg: GILL IN Robust Growth In Operating Margin Gillette India s or GIL s overall top-line performance

More information

Colgate-Palmolive (India)

Colgate-Palmolive (India) Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue

More information

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY 2QFY18 Result Update Institutional Equities Muthoot Finance 10 November 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Really Glitters Strong profitability numbers of Muthoot Finance (MFL)

More information

18,948 15,784 18, NIM

18,948 15,784 18, NIM 3QFY18 Result Update IndusInd Bank 12 January 2018 Reuters: INBK.BO; Bloomberg: IIB IN Alive to all Opportunities IndusInd Bank (IBL) reported its 3QFY18 results with the key strategic takeaways being

More information

Muthoot Finance. Institutional Equities. 1QFY19 Result Update

Muthoot Finance. Institutional Equities. 1QFY19 Result Update 1QFY19 Result Update Institutional Equities Muthoot Finance 6 September 2018 Reuters: MUTT.BO; Bloomberg: MUTH IN Sequential Gold Loan AUM Growth Accelerates Further Muthoot Finance (MFL) reported its

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Dalmia Bharat Enterprises 1 November 218 Reuters: DALA.BO; Bloomberg: DBEL IN Performance In Line; Stock Under Review Post Odisha Cement Amalgamation Dalmia Bharat Enterprises (DBEL) reported

More information

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017 1QFY18 Result Update Institutional Equities Muthoot Finance 10 August 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Continues To Glitter Strong profitability numbers of Muthoot Finance (MFL)

More information

Jamna Auto Industries

Jamna Auto Industries 2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were

More information

3,746 2,551 3, NIM

3,746 2,551 3, NIM 4QFY17 Result Update Institutional Equities Capital First 11 May 2017 Reuters: CAPF.BO; Bloomberg: CAFL IN Net Interest Income Up, But Offset By Elevated Credit Costs Although the net interest income or

More information

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY 3QFY17 Result Update Institutional Equities Manappuram Finance 9 February 2017 Reuters: MNFL.BO; Bloomberg: MGFL IN Profitability Beats Expectations Amid Some Spike In Loan Delinquency Strong Profit &

More information

Bharat Financial Inclusion

Bharat Financial Inclusion 3QFY18 Result Update Bharat Financial Inclusion Reuters: BHAF.NS; Bloomberg: BHAFIN IN 31 January 2018 Customer Acquisition Accelerates Meaningfully Bharat Financial Inclusion (BFIL) reported its 3QFY18

More information

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY 3QCY18 Result Update Institutional Equities Sanofi India Reuters: SANO.BO; Bloomberg: SANL IN Robust Performance Sanofi India s revenues in 3QCY18 stood at Rs7,438mn which were above our/consensus estimate

More information

EBITDA 5,076 3, , EBITDA

EBITDA 5,076 3, , EBITDA Result Update Ambuja Cements 21 February 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Healthy Volume Growth, Operating Costs Under Control Ambuja Cements (ACEM) reported a good set of numbers for owing to

More information

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution 2QFY19 Result Update Power Mech Projects 21 November 218 Reuters: POMP.BO; Bloomberg: POWM IN Strong Order Book Drives Robust Execution Power Mech Projects (PMPL) posted 2QFY19 consolidated revenues of

More information

9,500 7,914 8, NIM

9,500 7,914 8, NIM 3QFY18 Result Update Institutional Equities Federal Bank 16 January 2018 Reuters: FED.BO; Bloomberg: FB IN Quarter Typifies Balanced Growth Engine Federal Bank (FBL) reported 3QFY18 results with the key

More information

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1% 4QFY18 Result Update Institutional Equities ITC 17 May 2018 Reuters: ITC.NS; Bloomberg: ITC IN Tracking Expectations ITC s growth in 4QFY18 was modest and in line with expectations. On the revenue side,

More information

93,707 77,814 90, NIM

93,707 77,814 90, NIM 1QFY18 Result Update Institutional Equities HDFC Bank Reuters: HDBK.BO; Bloomberg: HDFCB IN Higher Fee Income Offsets Higher Provisioning HDFC Bank s net interest income or NII grew 20% in 1QFY18 driven

More information

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY 3QFY19 Result Update State Bank of India 4 February 2019 Reuters: SBI.BO; Bloomberg: SBIN IN Domestic Growth Continues To Accelerate State Bank of India (SBI) reported its 3QFY19 results with the key pointers

More information

Operating expenses tracked lower than core total income growth as ABL displayed continued

Operating expenses tracked lower than core total income growth as ABL displayed continued 1QFY19 Result Update Axis Bank 31 July 2018 Reuters: AXSB.BO; Bloomberg: AXSB IN Sub-investment Grade Book Portends Lower Credit Costs Axis Bank (ABL) reported 1QFY19 results with the key strategic pointers

More information

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY Event Update Institutional Equities NESCO 27 August 2018 Reuters: NSEN.NS; Bloomberg: NSE IN Revenues From Bombay Exhibition Centre May Take A Hit This event update relates to an application made on 14

More information

Punjab National Bank

Punjab National Bank 4QFY15 Result Update Institutional Equities Punjab National Bank 11 May 2015 Reuters: PNB.BO; Bloomberg: PNB IN Asset Quality Disappointment Continues Punjab National Bank (PNB) posted dismal 4QFY15 performance,

More information

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018 1QFY19 Result Update Institutional Equities South Indian Bank 23 July 2018 Reuters: SIBK.BO; Bloomberg: SIB IN Performance Troughs, Pessimism Peaks South Indian Bank (SBL) reported 1QFY19 results with

More information

Indian Oil Corporation

Indian Oil Corporation 4QFY18 Result Update Institutional Equities Indian Oil Corporation 24 May 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Subdued Earnings Because Of Lower GRM and Higher Expenses Indian Oil Corporation (IOCL)

More information

Punjab National Bank

Punjab National Bank 1QFY16 Result Update Institutional Equities Punjab National Bank 29 July 2015 Reuters: PNB.BO; Bloomberg: PNB IN Some Respite On Asset Quality Front Punjab National Bank (PNB) reported moderate 1QFY16

More information

Punjab National Bank

Punjab National Bank 1QFY18 Result Update Institutional Equities Punjab National Bank 3 August 2017 Reuters: PNB.BO; Bloomberg: PNB IN Asset Quality Continues To Disappoint Punjab National Bank s (PNB) annualised loan slippage

More information

Institutional Equities

Institutional Equities Economy Update March CPI Inflation/February IIP 15 April 2019 CPI Inflation Inches Up To 2.86%; IIP Growth Plunges To 0.1% Consumer Price Index or CPI inflation in March 2019 stood at 2.86%, slightly above

More information

DCB Bank. Institutional Equities. 3QFY19 Result Update. Decisive Move Into Higher RoE Trajectory BUY. 17 January 2019

DCB Bank. Institutional Equities. 3QFY19 Result Update. Decisive Move Into Higher RoE Trajectory BUY. 17 January 2019 3QFY19 Result Update Institutional Equities DCB Bank 17 January 2019 Reuters: DCBA.NS; Bloomberg: DCBB IN Decisive Move Into Higher RoE Trajectory DCB Bank (DBL) reported 3QFY19 results with the key pointers

More information

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19% 1QCY18 Result Update Institutional Equities Nestle India 11 May 218 Reuters: NEST.BO; Bloomberg: NEST IN Resurgence Continues Nestle India (NEST) reported strong overall performance during 1QCY18 driven

More information

9,251 7,812 8, NIM

9,251 7,812 8, NIM 4QFY15 Result Update Institutional Equities IndusInd Bank 17 April 2015 Reuters: INBK.BO; Bloomberg: IIB IN Yet Another Robust Performance IndusInd Bank s 4QFY15 profit beat our estimate by 12%. Its bottom-line

More information

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Bata India. Institutional Equities. 1QFY19 Result Update BUY 1QFY19 Result Update Institutional Equities Bata India 23 July 2018 Reuters: BATA.BO; Bloomberg: BATA IN Strong Margin Improvement To Drive Consensus EPS Upgrade Bata India s (BIL) YoY net sales growth

More information

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY Result Update Mangalam Cement 16 February 2018 Reuters: MGLC.BO; Bloomberg: MGC IN Higher Operating costs Hurt Performance Mangalam Cement (MGC) reported a weak performance for on account of higher operating

More information

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN Management Meet Update Institutional Equities Eicher Motors 17 July 2018 Reuters: EICH.NS; Bloomberg: EIM IN We had a meeting with the management of Eicher Motors (EML) recently. Following are the key

More information

9,807 8,007 9, NIM

9,807 8,007 9, NIM 1QFY16 Result Update Institutional Equities IndusInd Bank Reuters: INBK.BO; Bloomberg: IIB IN Yet Another Stellar Performance IndusInd Bank s 1QFY16 profit beat our estimate by 4%. Its bottom-line grew

More information

Institutional Equities

Institutional Equities Economy Update August CPI Inflation/ July IIP 14 September 2018 CPI Inflation Moderates To 3.69% YoY; IIP Growth Slows To 6.6% YoY Consumer Price Index or CPI inflation stood at 3.69% in August 2018, below

More information

Institutional Equities

Institutional Equities 1QFY19 Result Update Institutional Equities Aurobindo Pharma 13 August 2018 Reuters: ARBP.NS; Bloomberg: ARBP IN One-offs Impact Margin Aurobindo Pharma (APL) reported 1QFY19 revenues of Rs42,503mn which

More information

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA 1QFY19 Result Update The Ramco Cements 3 August 218 Reuters: TRCE.BO; Bloomberg: TRCL IN Challenging Business Environment Aptly Handled The Ramco Cements (TRCL) reported a stable operating performance

More information

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN 2QFY19 Result Update Maruti Suzuki India 26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN Better-than-expected Margins; Retain Buy Maruti Suzuki India (MSIL) s 2QFY19 earnings were 18% above our estimate

More information

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY Conference Update Institutional Equities Mold-Tek Packaging 20 August 2018 Reuters: MOLT.BO; Bloomberg: MTEP IN Promising Growth Outlook We recently interacted with the management of Mold-Tek Packaging

More information

Institutional Equities

Institutional Equities 3QFY18 Result Update Institutional Equities Atul Auto 15 February 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Drag Profitability Atul Auto s (AAL) 3QFY18 earnings missed our expectations

More information

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL 3QFY18 Result Update Institutional Equities Thermax 8 February 2018 Reuters: THMX.BO; Bloomberg: TMX IN Healthy Execution, But Margins Disappoint Thermax posted healthy execution in 3QFY18 with standalone

More information

Institutional Equities

Institutional Equities December 2017 Quarter Result Preview Institutional Equities Oil & Gas Sector 8 January 2018 Higher Crude Oil Prices To Result In Inventory Gains We expect 60%/4.4%/3.7%/6.5% QoQ growth in the December

More information

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE 1QFY19 Result Update Voltas 13 August 218 Reuters: VOLT.BO; Bloomberg: VOLT IN EMPS Shines, UCP Proves Its Mettle Again Voltas reported consolidated revenues of Rs21.5bn for 1QFY19, up 11% YoY and 5%/6%

More information

Federal Bank. Institutional Equities. Management Meet Update

Federal Bank. Institutional Equities. Management Meet Update Management Meet Update Institutional Equities Federal Bank 11 June 2018 Reuters: FED.BO; Bloomberg: FB IN Several Good Things in Store We recently met the CEO of Federal Bank (FBL), Mr Shyam Srinivasan

More information

State Bank of India. Institutional Equities. 1QFY18 Result Update

State Bank of India. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update Institutional Equities State Bank of India 14 August 2017 Reuters: SBI.BO; Bloomberg: SBIN IN Merger With Associate Banks Accentuates The Pain State Bank of India s (SBI) annualised

More information

EBITDA 6,223 6,511 (4.4) 5, EBITDA

EBITDA 6,223 6,511 (4.4) 5, EBITDA Result Update Institutional Equities Ambuja Cements 26 July 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Performance Beats Expectations, Sustainability Is Key Challenge Ambuja Cements (ACEM) reported steady

More information

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE 2QFY18 Result Update Institutional Equities Swaraj Engines 13 November 2017 Reuters: SWAR.BO; Bloomberg: SWE IN Strong Realisation Drives Earnings Growth Swaraj Engines (SEL) 2QFY18 earnings were 5% above

More information

Institutional Equities

Institutional Equities 2QFY18 Result Update Institutional Equities KCP 5 December 2017 Reuters: KCP.BO; Bloomberg: KCPL IN Other Income Drives PAT; High International Coal Price Is Cause For Concern KCP reported a weak set of

More information

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE 4QFY18 Result Update Institutional Equities Dabur India 3 May 2018 Reuters: DABU.NS; Bloomberg: DABUR IN Growth Volatility Is Still Fairly High Dabur India s (DABUR) consolidated top-line performance in

More information

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL 3QFY19 Result Update TVS Motor Company 23 January 2019 Reuters: TVSM.BO; Bloomberg: TVSL IN Better-Than-Expected Margins TVS Motor Company s 3QFY19 performance was above our expectations as it reported

More information

Institutional Equities

Institutional Equities 1QFY19 Result Update Institutional Equities Dr. Reddy s Laboratories 27 July 2018 Reuters: REDY.BO; Bloomberg: DRRD IN Drug Pipeline In Place, But Regulatory Hurdles Testing Patience Dr. Reddy s Laboratories

More information

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy 2QFY18 Result Update Power Mech Projects 23 November 217 Reuters: POMP.BO; Bloomberg: POWM IN Strong Business Scalability Likely; Retain Buy Power Mech Projects (PMPL) posted 2QFY18 consolidated revenues

More information

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport 3QCY17 Result Update Institutional Equities Crisil 18 October 2017 Reuters: CRSL.BO; Bloomberg: CRISIL IN Weak SME Rating Revenues & Currency Movement Play Spoilsport Crisil s 3QCY17 performance was below

More information

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA Result Update The India Cements 12 November 218 Reuters: ICMN.BO; Bloomberg: ICEM IN Lackluster Performance The India Cements (ICEM) reported a listless operating performance in because of the sustained

More information

The Ramco Cements. Institutional Equities. Event Update BUY

The Ramco Cements. Institutional Equities. Event Update BUY Event Update The Ramco Cements 21 December 2018 Reuters: TRCE.BO; Bloomberg: TRCL IN Capacity Expansion To Boost Its Presence In Andhra & Telangana The Ramco Cements (TRCL) has announced 3.15mt cement

More information

Axis Bank. Institutional Equities. 3QFY19 Result Update BUY. Management Says 18% RoE In The Realm Of Possibility. 30 January 2019

Axis Bank. Institutional Equities. 3QFY19 Result Update BUY. Management Says 18% RoE In The Realm Of Possibility. 30 January 2019 3QFY19 Result Update Axis Bank 30 January 2019 Reuters: AXSB.BO; Bloomberg: AXSB IN Management Says 18% RoE In The Realm Of Possibility Axis Bank (ABL) reported 3QFY19 results with the key pointers being:

More information

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE Event Update Institutional Equities ACC 19 December 218 Reuters: ACC.BO; Bloomberg: ACC IN Capacity Expansion To Consolidate Presence In Central India ACC has announced 5.9mt capacity expansion by adding

More information

Bank of Baroda. Institutional Equities. 4QFY18 Result Update BUY

Bank of Baroda. Institutional Equities. 4QFY18 Result Update BUY 4QFY18 Result Update Institutional Equities Bank of Baroda Reuters: BOB.BO; Bloomberg: BOB IN Stress Peaks, Underlying Business Transforming; Upgrade To Buy Bank of Baroda (BoB) reported its 4QFY18 results

More information

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update 4QFY18 Result Update Institutional Equities Hindustan Unilever 15 May 2018 Reuters: HLL.BO; Bloomberg: HUVR IN Reaping Rewards Of Consistency 4QFY18 was the third consecutive quarter wherein Hindustan

More information

Dabur India. Institutional Equities. 1QFY19 Result Update

Dabur India. Institutional Equities. 1QFY19 Result Update 1QFY19 Result Update Institutional Equities Dabur India 2 August 2018 Reuters: DABU.NS; Bloomberg: DABUR IN Consistency Is Key To The Game Dabur India s (DABUR) operating performance in 1QFY19 was better

More information

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 2904 Recommendation CMP Target Price BUY Rs. 312 Rs. 443 Better times ahead! reported a good set of numbers in

More information

Institutional Equities

Institutional Equities Economy Update Institutional Equities May Inflation/April Index of Industrial Production 13 June 2018 CPI Inflation At 4.9%; IIP Growth Also At 4.9% Consumer Price Index or CPI inflation in India stood

More information

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy 4QFY16 Result Update Institutional Equities Timken India 23 May 2016 Reuters: TMKN.BO; Bloomberg: TIMK IN Margin Expansion Leads To Huge Growth In Profit; Retain Buy Timken India (TIL), the leading manufacturer

More information

Institutional Equities

Institutional Equities 3QFY15 Result Update Institutional Equities GlaxoSmithKline Consumer Healthcare Reuters: GLSM.BO; Bloomberg: SKB IN 4 February 2015 Price Hike Leads To Sales Growth Glaxo SmithKline Consumer Healthcare

More information

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY. 3QFY18 Result Update Institutional Equities IFB Industries Reuters: IFBI.BO; Bloomberg: IFBI IN Healthy Revenues, Strong Gross Margin; Retain Buy IFB Industries (IFB) posted a healthy 17% YoY rise in net

More information

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update 1QFY19 Result Update Institutional Equities Hindustan Unilever 17 July 218 Reuters: HLL.BO; Bloomberg: HUVR IN Breakout Growth Hindustan Unilever (HUVR) has delivered strong volume led top-line growth

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Institutional Equities Dalmia Bharat Enterprises Reuters: DALA.BO; Bloomberg: DBEL IN 14 August 218 Listless Performance, But Valuation Premium Continues Dalmia Bharat Enterprises (DBEL)

More information

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA Result Update Institutional Equities The India Cements 28 May 218 Reuters: ICMN.BO; Bloomberg: ICEM IN Fall In Realisation, Higher Operating Costs Hurt Performance The India Cements (ICEM) reported a weak

More information

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY 2QFY18 Result Update Institutional Equities CARE Ratings 17 November 217 Reuters: CREI.BO; Bloomberg: CARE IN Mixed Performance CARE Ratings (CARE) reported an increase of 12.3% in revenues for 2QFY18

More information

Institutional Equities

Institutional Equities Event Update Institutional Equities Aurobindo Pharma 10 September 2018 Reuters: ARBP.NS; Bloomberg: ARBP IN Acquires Dermatology and Oral Solids Businesses Of Sandoz Aurobindo Pharma s (APL) acquisition

More information

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely 4QFY15 Result Update Crompton Greaves 29 May 2015 Reuters: CROM.BO; Bloomberg: CRG IN Overseas Losses Continue; More Business Exits Likely The 4QFY15 performance of Crompton Greaves (CGL) was below expectation

More information

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY 1QFY19 Result Update Sequent Scientific 13 August 2018 Reuters: SEQU.BO; Bloomberg: SEQ IN Regulatory Changes And Adverse Forex Movement Dampens Momentum Sequent Scientific or SSL s revenues at Rs2,369mn

More information

Institutional Equities

Institutional Equities Company Update Institutional Equities Dr. Reddy s Laboratories 5 September 2017 Reuters: REDY.BO; Bloomberg: DRRD IN Suboxone Generic Opportunity To Be Lucrative, Can Sustain For Longer Time The district

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Dalmia Bharat Enterprises Reuters: DALA.BO; Bloomberg: DBEL IN 22 May 218 Healthy Performance Led By Good Volume Growth Dalmia Bharat Enterprises (DBEL) reported a healthy performance for

More information

EBITDA 5,019 4,211 5, EBITDA

EBITDA 5,019 4,211 5, EBITDA Result Update Institutional Equities Dalmia Bharat Reuters: DALA.BO; Bloomberg: DBEL IN Outperformance Likely To Continue Dalmia Bharat (DBL) reported a good set of numbers for, given the challenging environment

More information

Initiating Coverage. Uflex Ltd.

Initiating Coverage. Uflex Ltd. 2904 Recommendation CMP Target Price BUY Rs. 283 Rs. 444 Better times ahead! reported a good set of numbers for the year FY18 and for Q4. Sales for the quarter increase by 11.8% YoY to Rs 1809.8 Cr and

More information

Valuation and Outlook. Growth (%) PAT (Rs cr)

Valuation and Outlook. Growth (%) PAT (Rs cr) Feb-18 May-18 Aug-18 Nov-18 Feb-19 4 Recommendation Hold CMP Rs. 67 Target Price Rs. 90 Sector Stock Details Banking BSE Code 590003 NSE Code Bloomberg Code KARURVYSYA KVB IN Market Cap (Rs Cr) Rs. 5,355

More information

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update 3QFY15 Result Update Institutional Equities Bajaj Electricals 13 February 2015 Reuters: BJEL.BO; Bloomberg: BJE IN Final Phase Of Transition Pain; Retain Buy Bajaj Electricals (BJE) posted 3QFY15 revenue

More information

Institutional Equities

Institutional Equities 10 April 2019 4QFY19 Result Preview Gains Versus El Nino Headwind Holds The Key; Retain Buy We remain positive on and retain our Buy call on it based on 24% upside to our blended target price of Rs1,134

More information

Institutional Equities

Institutional Equities Management Meet Update Institutional Equities Kaya Reuters: KAYA.NS; Bloomberg: KAYA IN We interacted with the management of Kaya at an investor conference held by us recently. Following are the key takeaways:

More information

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1% Management Meet Update Bata India Reuters: BATA.BO; Bloomberg: BATA IN On Right Track We had a meeting recently with Mr. R. K. Gupta, Chief Financial Officer (CFO) of Bata India (BIL) to understand recent

More information

Institutional Equities

Institutional Equities March 2018 Quarter Result Preview Institutional Equities FMCG Sector 6 April 2018 Strong Fundamentals To Support High-teen Growth We expect the companies in our FMCG coverage universe to maintain their

More information

E&P To Stay Strong; Consumer Segment To Revive

E&P To Stay Strong; Consumer Segment To Revive Management Meet Update Institutional Equities Bajaj Electricals 30 August 2017 Reuters: BJEL.BO; Bloomberg: BJE IN E&P To Stay Strong; Consumer Segment To Revive We had a meeting with the management of

More information

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536 4QFY17 Result Update La Opala RG 11 May 217 Reuters: LAOP.BO; Bloomberg: LOG IN Revenues Soar, But Margins Take A Hit La Opala RG (LORL) reported revenues of Rs761mn for 4QFY17, up 41% YoY. The stellar

More information

Institutional Equities

Institutional Equities 2QFY13 Result Update Institutional Equities Reliance Infrastructure 7 November 2012 Reuters: RELIN.BO; Bloomberg: RELI IN Project Execution On Track Reliance Infrastructure reported revenue decline of

More information

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514 3QFY15 Result Update Institutional Equities Cadila Healthcare 11 February 2015 Reuters: CADI.BO; Bloomberg: CDH IN Stable Performance Cadila Healthcare s (CHL) 3QFY15 earnings were in line with our expectations

More information

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017 Management Meet Update Atul Auto 23 August 2017 Reuters: ATUL.BO; Bloomberg: ATUL IN We had a meeting with the management of Atul Auto (AAL) recently to gauge its performance in the aftermath of a relatively

More information

Financial summary. Year

Financial summary. Year : price: ABV: How does our one year outlook change? We retain our positive outlook on KVB, led by an improving margin profile and cost containment kicking in, while our key thesis - a proven sole banking

More information